These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22875412)

  • 41. [NT-proBNP for risk stratification of pulmonary embolism].
    Dores H; Fonseca C; Leal S; Rosário I; Abecasis J; Monge J; Correia MJ; Bronze L; Leitão A; Arroja I; Aleixo A; Silva A
    Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.
    Huijts M; van Oostenbrugge RJ; Duits A; Burkard T; Muzzarelli S; Maeder MT; Schindler R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Jun; 15(6):699-707. PubMed ID: 23384944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
    Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
    Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
    Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
    Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
    J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study.
    Cleland JG; Taylor J; Freemantle N; Goode KM; Rigby AS; Tendera M
    Eur J Heart Fail; 2012 May; 14(5):487-94. PubMed ID: 22505395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
    Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
    Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
    Lainchbury JG; Troughton RW; Strangman KM; Frampton CM; Pilbrow A; Yandle TG; Hamid AK; Nicholls MG; Richards AM
    J Am Coll Cardiol; 2009 Dec; 55(1):53-60. PubMed ID: 20117364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
    J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients.
    Pascual-Figal DA; Domingo M; Casas T; Gich I; Ordoñez-Llanos J; Martínez P; Cinca J; Valdés M; Januzzi JL; Bayes-Genis A
    Eur Heart J; 2008 Apr; 29(8):1011-8. PubMed ID: 18263871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.
    Skali H; Dwyer EM; Goldstein R; Haigney M; Krone R; Kukin M; Lichstein E; McNitt S; Moss AJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2014 May; 16(5):560-5. PubMed ID: 24578164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged impact of home versus clinic-based management of chronic heart failure: extended follow-up of a pragmatic, multicentre randomized trial cohort.
    Stewart S; Carrington MJ; Horowitz JD; Marwick TH; Newton PJ; Davidson PM; Macdonald P; Thompson DR; Chan YK; Krum H; Reid C; Scuffham PA
    Int J Cardiol; 2014 Jul; 174(3):600-10. PubMed ID: 24825029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients.
    Kuschyk J; Roeger S; Schneider R; Streitner F; Stach K; Rudic B; Weiß C; Schimpf R; Papavasilliu T; Rousso B; Burkhoff D; Borggrefe M
    Int J Cardiol; 2015 Mar; 183():76-81. PubMed ID: 25662055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of multidisciplinary outpatient management (MOM) program in long term heart failure care.
    Jain R; Evenson A; Jain R; Biddison E; Dalal D; Kelly KM; Karmand AJ; Hullsiek H; Punnam J; Plantholt S
    South Med J; 2010 Feb; 103(2):131-7. PubMed ID: 20065904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial.
    Malmborg M; Assad Turky Al-Kahwa A; Kober L; Torp-Pedersen C; Butt JH; Zahir D; Tuxen CD; Poulsen MK; Madelaire C; Fosbol E; Gislason G; Hildebrandt P; Andersson C; Gustafsson F; Schou M
    PLoS One; 2023; 18(6):e0286307. PubMed ID: 37289772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.